Grace Therapeutics (GRCE) Shares Outstanding (Diluted) (2021 - 2026)
Grace Therapeutics' Shares Outstanding (Diluted) came in at 17.27 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 8.4% from 15.92 million a year earlier and up 4.6% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Grace Therapeutics' Shares Outstanding (Diluted) was 16.51 million, up 36.6% from FY2025.
- Shares Outstanding (Diluted) has increased in each of the last four fiscal years, with a four-year compound annual growth rate of 28.1% (FY2022 to FY2026).
- Going back by fiscal year, Shares Outstanding (Diluted) was 12.09 million in FY2025 (+26.8%), 9.53 million in FY2024 (+28.2%), 7.44 million in FY2023 (+21.1%) and 6.14 million in FY2022.
- The fiscal Q1 2027 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q1 2022.
- Year-over-year, Shares Outstanding (Diluted) has increased for six consecutive quarters, with growth averaging 31.9% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.0% (fiscal Q3 2025) and 70.2% (fiscal Q1 2023) over the last five years.
- Business Quant data shows GRCE's Shares Outstanding (Diluted) at 16.51 million (Q4 2026), 16.93 million (Q3 2026) and 15.92 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Grace Therapeutics | 34.99 Mn | 34.99 Mn | - | 17.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.27 Mn |
| Mar 31, 2026 | 16.51 Mn |
| Dec 31, 2025 | 16.93 Mn |
| Sep 30, 2025 | 15.92 Mn |
| Jun 30, 2025 | 15.92 Mn |
| Mar 31, 2025 | 12.09 Mn |
| Dec 31, 2024 | 11.51 Mn |
| Sep 30, 2024 | 11.51 Mn |
| Jun 30, 2024 | 10.93 Mn |
| Mar 31, 2024 | 9.53 Mn |
| Dec 31, 2023 | 11.51 Mn |
| Sep 30, 2023 | 7.55 Mn |
| Jun 30, 2023 | 7.44 Mn |
| Mar 31, 2023 | 7.44 Mn |
| Dec 31, 2022 | 7.44 Mn |
| Sep 30, 2022 | 7.43 Mn |
| Jun 30, 2022 | 7.39 Mn |
| Mar 31, 2022 | 6.14 Mn |
| Dec 31, 2021 | 7.38 Mn |
| Sep 30, 2021 | 5.46 Mn |
API Access
Grace Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();